Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 18 results.
User Information
Export Records
  1. 1.   Prevalence and Significance of Plasmid Maintenance Functions in the Virulence Plasmids of Pathogenic Bacteria
  2. Sengupta, M.; Austin, S.
  3. Infection and Immunity. 2011, Jul; 79(7): 2502-2509.
  1. 2.   Novel Broad-Spectrum Bis-(Imidazolinylindole) Derivatives with Potent Antibacterial Activities against Antibiotic-Resistant Strains
  2. Panchal, R. G.; Ulrich, R. L.; Lane, D.; Butler, M. M.; Houseweart, C.; Opperman, T.; Williams, J. D.; Peet, N. P.; Moir, D. T.; Nguyen, T.; Gussio, R.; Bowlin, T.; Bavari, S.
  3. Antimicrobial Agents and Chemotherapy. 2009 53(10): 4283-4291.
  1. 3.   Effect of CpG oligonucleotides on vaccine-induced B cell memory
  2. Tross, D.; Klinman, D. M.
  3. Journal of Immunology. 2008 181(8): 5785-5790.
  1. 4.   Chemical genetic screening identifies critical pathways in anthrax lethal toxin-induced pathogenesis
  2. Panchal, R. G.; Ruthel, G.; Brittingham, K. C.; Lane, D.; Kenny, T. A.; Gussio, R.; Lazo, J. S.; Bavari, S.
  3. Chemistry & Biology. 2007, Mar; 14(3): 245-255.
  1. 5.   Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice
  2. Lee, J. S.; Groebner, J. L.; Hadjipanayis, A. G.; Negley, D. L.; Schmaljohn, A. L.; Welkos, S. L.; Smith, L. A.; Smith, J. F.
  3. Vaccine. 2006, Nov; 24(47-48): 6886-6892.
  1. 6.   Quality sample collection, handling, and preservation for an effective microbial forensics program
  2. Budowle, B.; Schutzer, S. E.; Burans, J. P.; Beecher, D. J.; Cebula, T. A.; Chakraborty, R.; Cobb, W. T.; Fletcher, J.; Hale, M. L.; Harris, R. B.; Heitkamp, M. A.; Keller, F. P.; Kuske, C.; LeClerc, J. E.; Marrone, B. L.; McKenna, T. S.; Morse, S. A.; Rodriguez, L. L.; Valentine, N. B.; Yadev, J.
  3. Applied and Environmental Microbiology. 2006, Oct; 72(10): 6431-6438.
  1. 7.   Anthrax vaccines: Pasteur to the present
  2. Scorpio, A.; Blank, T. E.; Day, W. A.; Chabot, D. J.
  3. Cellular and Molecular Life Sciences. 2006, Oct; 63(19-20): 2237-2248.
  1. 8.   Enhancing molecular flux through nanopores by means of attractive interactions
  2. Kasianowicz, J. J.; Nguyen, T. L.; Stanford, V. M.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, Aug; 103(31): 11431-11432.
  1. 9.   Anthrax biosensor, protective antigen ion channel asymmetric blockade
  2. Halverson, K. M.; Panchal, R. G.; Nguyen, T. L.; Gussio, R.; Little, S. F.; Misakian, M.; Bavari, S.; Kasianowicz, J. J.
  3. Journal of Biological Chemistry. 2005, OCT 7; 280(40): 34056-34062.
  1. 10.   Dendritic cells endocytose Bacillus anthracis spores: Implications for anthrax pathogenesis
  2. Brittingham, K. C.; Ruthel, G.; Panchal, R. G.; Fuller, C. L.; Ribot, W. J.; Hoover, T. A.; Young, H. A.; Anderson, A. O.; Bavari, S.
  3. Journal of Immunology. 2005, MAY 1; 174(9): 5545-5552.
  1. 11.   Purified Bacillus anthracis lethal toxin complex formed in Vitro and during infection exhibits functional and biological activity
  2. Panchal, R. G.; Halverson, K. M.; Ribot, W.; Lane, D.; Kenny, T.; Abshire, T. G.; Ezzell, J. W.; Hoover, T. A.; Powell, B.; Little, S.; Kasianowicz, J. J.; Bavari, S.
  3. Journal of Biological Chemistry. 2005, MAR 18; 280(11): 10834-10839.
  1. 12.   Construction of a rhamnose mutation in Bacillus anthracis affects adherence to macrophages but not virulence in guinea pigs
  2. Bozue, J. A.; Parthasarathy, N.; Phillips, L. R.; Cote, C. K.; Fellows, P. F.; Mendelson, I.; Shafferman, A.; Friedl, er
  3. Microbial Pathogenesis. 2005, JAN; 38(1): 1-12.
  1. 13.   Involvement of domain II in toxicity of anthrax lethal factor
  2. Liang, X. D.; Young, J. J.; Boone, S. A.; Waugh, D. S.; Duesbery, N. S.
  3. Journal of Biological Chemistry. 2004, DEC 10; 279(50): 52473-52478.
  1. 14.   Identification of small molecule inhibitors of anthrax lethal factor
  2. Panchal, R. G.; Hermone, A. R.; Nguyen, T. L.; Wong, T. Y.; Schwarzenbacher, R.; Schmidt, J.; Lane, D.; McGrath, C.; Turk, B. E.; Burnett, J.; Aman, M. J.; Little, S.; Sausville, E. A.; Zaharevitz, D. W.; Cantley, L. C.; Liddington, R. C.; Gussio, R.; Bavari, S.
  3. Nature Structural & Molecular Biology. 2004 11(1): 67-72.
  1. 15.   Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants
  2. Jendrek, S.; Little, S. F.; Hem, S.; Mitra, G.; Giardina, S.
  3. Vaccine. 2003 21(21-22): 3011-3018.
  1. 16.   Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways
  2. Duesbery, N. S.; Resau, J.; Webb, C. P.; Koochekpour, S.; Koo, H. M.; Leppla, S. H.; Woude, G. F. V.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2001 98(7): 4089-4094.
  1. 17.   Anthrax toxins
  2. Duesbery, N. S.; Vande Woude, G. F.
  3. Cellular and Molecular Life Sciences. 1999 55(12): 1599-1609.
  1. 18.   Proteolytic Inactivation of Map-Kinase-Kinase By Anthrax Lethal Factor
  2. Duesbery, N. S.; Webb, C. P.; Leppla, S. H.; Gordon, V. M.; Klimpel, K. R.; Copeland, T. D.; Ahn, N. G.; Oskarsson, M. K.; Fukasawa, K.; Paull, K. D.; Vande Woude, G. F.
  3. Science. 1998 280(5364): 734-737.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel